The number of cells showing subcellular co-localization of COL5A1 and NOX2 was significantly increased in patients with GBM (G4) and G3 glioma (G3) compared to that in G1 and G2 glioma (Figure 6c). Here, CYBB is linked to central nervous system cancer.